Acetic Acid → 1-(4-(4-((Cyclobutylamino)methyl)phenyl)piperazin-1-yl)ethanone
Reaction equation
[C:1]([N:4]1[CH2:9][CH2:8][N:7]([C:10]2[CH:17]=[CH:16][C:13]([CH:14]=O)=[CH:12][CH:11]=2)[CH2:6][CH2:5]1)(=[O:3])[CH3:2].[CH:18]1([NH2:22])[CH2:21][CH2:20][CH2:19]1.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+].C(O)(=O)C>ClC(Cl)C>[CH:18]1([NH:22][CH2:14][C:13]2[CH:16]=[CH:17][C:10]([N:7]3[CH2:8][CH2:9][N:4]([C:1](=[O:3])[CH3:2])[CH2:5][CH2:6]3)=[CH:11][CH:12]=2)[CH2:21][CH2:20][CH2:19]1Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 4-(4-acetylpiperazin-1-yl)benzaldehyde (150 mg, 0.64 mmol) and cyclobutylamine (75 mg, 0.77 mmol) in dichloroethane (1.5 mL) was added sodium triacetoxyborohydride (216 mg, 0.96 mmol), followed by acetic acid (0.055 mL, 0.96 mmol) and the reaction was stirred at ambient temperature for 16 hours. The reaction was then quenched with 1 N aqueous NaOH, diluted with dichloromethane and the dichloromethane layer was isolated with a phase-separator cartridge and concentrated to give 1-(4-(4-((cyclobutylamino)methyl)phenyl)piperazin-1-yl)ethanone (185 mg). The product was used without purification. LCMS (m/z) ES+ 288 [M+1]+.
Workup
- customThe reaction was then quenched with 1 N aqueous NaOH
- additiondiluted with dichloromethane
- customthe dichloromethane layer was isolated with a phase-separator cartridge
- concentrationconcentrated
Sources & evidence
- ORD record
- ord-ef63b15ff3904cf69264c4e7781df821
- Source dataset
- uspto-grants-2015_12
- Patent number
- US09216988B2
Reaction notes
Loading…